Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | STAT3 | P40763 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.36 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL113464 | 0.87 | IGF1R (0.40) | TYRCNR1SKP2 | |
| SCHEMBL8498153 | 0.85 | ESR1 (0.57) | TYRLMNACNR1ESR1ESR2 | |
| SCHEMBL18926474 | 0.83 | MMP1 (0.40) | LMNASMN1; SMN2MMP1MMP2MMP3 | |
| SCHEMBL29027711 | 0.83 | KCNH2 (0.44) | LMNASMN1; SMN2CNR1KCNH2PTGS2 | |
| SCHEMBL16973527 | 0.80 | SLC6A2 (0.43) | LMNASMN1; SMN2MMP1MMP2MMP3 | |
| SCHEMBL29027781 | 0.79 | OPRM1 (0.41) | HRH3 | |
| SCHEMBL5312432 | 0.78 | CNR1 (0.37) | LMNASMN1; SMN2STAT3MMP1MMP2 | |
| SCHEMBL11052107 | 0.78 | STAT3 (0.35) | LMNASMN1; SMN2STAT3MMP1MMP2 | |
| SCHEMBL112277 | 0.78 | SKP2 (0.39) | MMP1MMP2MMP3CNR1SKP2 | |
| SCHEMBL311370 | 0.78 | PTGS1 (0.45) | LMNACNR1ESR1ESR2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1651037-A1 | SECONDARY ALCOHOLS USED AS ANTIMICROBIAL AGENTS | Symrise GmbH & Co. KG (DE) | 2006-05-03 | — | — | EP | claimed |
| WO-2005004601-A1 | SECONDARY ALCOHOLS USED AS ANTIMICROBIAL AGENTS | SYMRISE GMBH & CO. KG (DE) | 2005-01-20 | — | — | WO | claimed |
| EP-2424829-B1 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE AG (DE) | 2015-01-07 | — | — | EP | disclosed |
| US-8623340-B2 | Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor | SYMRISE AG (DE) | 2014-01-07 | — | — | US | disclosed |
| US-20120107258-A1 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE AG (DE) | 2012-05-03 | — | — | US | disclosed |
| EP-2424829-A2 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | Symrise AG (DE) | 2012-03-07 | — | — | EP | disclosed |
| WO-2009101216-A2 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE GMBH & CO. KG (DE) | 2009-08-20 | — | — | WO | disclosed |
| US-20090123392-A1 | FRAGRANCE ACCORDS TO COMBAT THE PERCEPTION OF BODY ODOR | SYMRISE GMBH & CO. KG (DE) | 2009-05-14 | — | — | US | disclosed |
| EP-2014273-A1 | Use of methyl methyl ether and another ether to provide a feeling of cleanliness and purity | Symrise GmbH & Co. KG (DE) | 2009-01-14 | — | — | EP | disclosed |
| EP-1651037-A1 | SECONDARY ALCOHOLS USED AS ANTIMICROBIAL AGENTS | Symrise GmbH & Co. KG (DE) | 2006-05-03 | — | — | EP | disclosed |
| WO-2005004601-A1 | SECONDARY ALCOHOLS USED AS ANTIMICROBIAL AGENTS | SYMRISE GMBH & CO. KG (DE) | 2005-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120107258-A1 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | ALOX12, ALOX15, ALOX15B | TYR 251/4885LMNA 3689/4885SMN1; SMN2 3775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.